Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep;11(5):e200302.
doi: 10.1212/NXI.0000000000200302. Epub 2024 Aug 12.

Should We Measure CSF Complement Levels in Patients With MOGAD?

Affiliations
Editorial

Should We Measure CSF Complement Levels in Patients With MOGAD?

Carson E Moseley et al. Neurol Neuroimmunol Neuroinflamm. 2024 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

C.E. Moseley is supported by a Clinician Scientist Development Award Grant FAN-2107-38301 from the National Multiple Sclerosis Society, a Clinician-Scientist Award from the Weill Neurohub, and the C.D. Spangler Foundation. S.S. Zamvil is supported by National Institutes of Health grants 1 R01 AI131624-01A1 and 1 R01 AI170863-01A1, the Sumaira Foundation, and the Weill Institute for Neurosciences. Go to Neurology.org/NN for full disclosures.

References

    1. Wingerchuk DM, Lucchinetti CF. Neuromyelitis optica spectrum disorder. N Engl J Med. 2022;387(7):631-639. doi:10.1056/NEJMra1904655 - DOI - PubMed
    1. Pittock SJ, Berthele A, Fujihara K, et al. . Eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder. N Engl J Med. 2019;381(7):614-625. doi:10.1056/NEJMoa1900866 - DOI - PubMed
    1. Banwell B, Bennett JL, Marignier R, et al. . Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023;22(3):268-282. doi:10.1016/S1474-4422(22)00431-8 - DOI - PubMed
    1. Sabatino JJ, Pröbstel A-K, Zamvil SS. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci. 2019;20(12):728-745. doi:10.1038/s41583-019-0233-2 - DOI - PubMed
    1. Takai Y, Misu T, Kaneko K, et al. . Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431-1446. doi:10.1093/brain/awaa102 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources